{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T22:25:29Z","timestamp":1757543129456},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1995,3,1]],"date-time":"1995-03-01T00:00:00Z","timestamp":794016000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[1995,3]]},"DOI":"10.1007\/bf02245832","type":"journal-article","created":{"date-parts":[[2005,11,15]],"date-time":"2005-11-15T04:53:00Z","timestamp":1132030380000},"page":"142-149","source":"Crossref","is-referenced-by-count":14,"title":["Persistent catalepsy associated with severe dyskinesias in rats treated with chronic injections of haloperidol decanoate"],"prefix":"10.1007","volume":"118","author":[{"given":"T. M.","family":"Hyde","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. R.","family":"Weinberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. E.","family":"Kleinman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. F.","family":"Egan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. L.","family":"Wing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. J.","family":"Wyatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02245832_CR1","first-page":"78","volume-title":"Principles of neurology","author":"RD Adams","year":"1989","unstructured":"Adams RD, Victor M (1989) Tremor, myoclonus, spasm and tics. In: Principles of neurology, 4th edition. McGraw-Hill, New York, pp 78\u201379","edition":"4th edition"},{"key":"BF02245832_CR2","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/0166-2236(89)90074-X","volume":"12","author":"RL Albin","year":"1989","unstructured":"Albin RL, Young AB, Penney JB (1989) The functional anatomy of basal ganglia disorders. Trends Neurosci 12:366\u2013375","journal-title":"Trends Neurosci"},{"key":"BF02245832_CR3","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1146\/annurev.ne.09.030186.002041","volume":"9","author":"GE Alexander","year":"1986","unstructured":"Alexander GE, DeLong MR, Strick PL (1986) Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 9:357\u2013381","journal-title":"Annu Rev Neurosci"},{"key":"BF02245832_CR4","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1212\/WNL.42.6.1241","volume":"42","author":"F Baronti","year":"1992","unstructured":"Baronti F, Mouradian MM, Conant KE, Giuffra M, Brughitta G, Chase TN (1992) Partial dopamine agonist therapy of levodopainduced dyskinesias. Neurology 42:1241\u20131243","journal-title":"Neurology"},{"key":"BF02245832_CR5","first-page":"39","volume":"39","author":"RCH Bell","year":"1978","unstructured":"Bell RCH, Smith RC (1978) Tardive dyskinesia: characterization and prevalence in a state-wide system. J Clin Psychiatry 39:39\u201347","journal-title":"J Clin Psychiatry"},{"key":"BF02245832_CR6","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1212\/WNL.40.6.927","volume":"40","author":"S Boyce","year":"1990","unstructured":"Boyce S, Rupniak NMJ, Steventon MJ, Iversen SD (1990) Differential effects of D1 and D2 agonists in MPTP-treated primates. Neurology 40:927\u2013933","journal-title":"Neurology"},{"key":"BF02245832_CR7","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1192\/bjp.118.543.171","volume":"118","author":"S Brandon","year":"1971","unstructured":"Brandon S, McClelland HA, Protheroe C (1971) A study of facial dyskinesia in a mental hospital population. Br J Psychiatry 118:171\u2013184","journal-title":"Br J Psychiatry"},{"key":"BF02245832_CR8","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0006-3223(91)90042-K","volume":"29","author":"MP Caligiuri","year":"1991","unstructured":"Caligiuri MP, Lohr JB, Bracha HS, Jeste DV (1991) Clinical and instrumental assessment of neuroleptic-induced parkinsonism in patients with tardive dyskinesia. Biol Psychiatry 29:139\u2013148","journal-title":"Biol Psychiatry"},{"key":"BF02245832_CR9","first-page":"221","volume":"14","author":"DE Casey","year":"1988","unstructured":"Casey DE (1988) Affective disorders and tardive dyskinesia. L'Encephale 14:221\u2013226","journal-title":"L'Encephale"},{"key":"BF02245832_CR10","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1176\/ajp.136.1.79","volume":"136","author":"G Chouinard","year":"1979","unstructured":"Chouinard G, Annable L, Ross-Chouinard A et al. (1979) Factors related to tardive dyskinesia. Am J Psychiatry 136:79\u201383","journal-title":"Am J Psychiatry"},{"key":"BF02245832_CR11","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1001\/archneur.1972.00490170058008","volume":"27","author":"GE Crane","year":"1972","unstructured":"Crane GE (1972) Pseudoparkinsonism and tardive dyskinesia. Arch Neurol 27:426\u2013430","journal-title":"Arch Neurol"},{"key":"BF02245832_CR12","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1152\/jn.1985.53.2.530","volume":"53","author":"MR DeLong","year":"1985","unstructured":"DeLong MR, Crutcher MD, Georgopoulos AP (1985) Primate globus pallidus and subthalamic nucleus: functional organization. J Neurophysiol 53:530\u2013543","journal-title":"J Neurophysiol"},{"key":"BF02245832_CR13","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0014-2999(91)90457-2","volume":"199","author":"MF Egan","year":"1995","unstructured":"Egan MF, Karoum F, Wyatt RJ (1995) Effects of acute and chronic clozapine and haloperidol administration on 3-methoxytyramine accumulation in the rat prefrontal cortex, nucleus accumbens, striatum. Eur J Pharmacol 199:191\u2013199","journal-title":"Eur J Pharmacol"},{"key":"BF02245832_CR14","doi-asserted-by":"crossref","unstructured":"Egan MF, Hyde TM, Wyatt RJ, Kleinman JE (1995) Neurolepticinduced vacuous chewing movements in rodents: incidence and effects of long-term increases in haloperidol doses. Psychopharmacology (in press)","DOI":"10.1007\/BF02245101"},{"key":"BF02245832_CR15","first-page":"182","volume":"33","author":"WE Fann","year":"1972","unstructured":"Fann WE, Davis JM, Janowsky DS (1972) The prevalence of tardive dyskinesia in mental hospital patients. Dis Nerv Syst 33:182\u2013186","journal-title":"Dis Nerv Syst"},{"key":"BF02245832_CR16","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1176\/ajp.140.2.200","volume":"140","author":"G Gardos","year":"1983","unstructured":"Gardos G, Cole JO (1983) Tardive dyskinesia and anticholinergic drugs. Am J Psychiatry 140:200\u2013202","journal-title":"Am J Psychiatry"},{"key":"BF02245832_CR17","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1126\/science.2147780","volume":"250","author":"CR Gerfen","year":"1990","unstructured":"Gerfen CR, Engber TM, Mahan LC, Susel Z, Chase TN, Monsma FJ, Sibley DR (1990) D1 and D2 receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250:1429\u20131432","journal-title":"Science"},{"key":"BF02245832_CR18","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/BF00431935","volume":"77","author":"LM Gunne","year":"1982","unstructured":"Gunne LM, Growdon J, Glaeser B (1982) Oral dyskinesia in rats following brain lesions and neuroleptic drug administration. Psychopharmacology 77:134\u2013139","journal-title":"Psychopharmacology"},{"key":"BF02245832_CR19","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1136\/jnnp.51.6.850","volume":"51","author":"RJ Hardie","year":"1988","unstructured":"Hardie RJ, Lees AJ (1988) Neuroleptic-induced Parkinson's syndrome: clinical features and results of treatment with levodopa. J Neurol Neurosurg Psychiatry 51:850\u2013854","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BF02245832_CR20","first-page":"13","volume":"44","author":"RS Hausner","year":"1986","unstructured":"Hausner RS (1986) Neuroleptic-induced parkinsonism and Parkinson's disease. J Clin Psychiatry 44:13\u201316","journal-title":"J Clin Psychiatry"},{"key":"BF02245832_CR21","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/BF02244814","volume":"106","author":"J Hietala","year":"1992","unstructured":"Hietala J, Sepp\u00e4l\u00e4 T, Lappalainen J, Syv\u00e4laht, E (1992) Quantification of SCH 39166, a novel selective D1 dopamine receptor antagonist, in rat brain and blood. Psychopharmacology 106:455\u2013458","journal-title":"Psychopharmacology"},{"key":"BF02245832_CR22","first-page":"758","volume":"57","author":"R Hunter","year":"1964","unstructured":"Hunter R, Ear, CJ, Thornicroft S (1964) An apparently irreversible syndrome of abnormal movements following phenothiazine medication. Proc R Soc Med 57:758\u2013762","journal-title":"Proc R Soc Med"},{"key":"BF02245832_CR23","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/00002826-198712000-00002","volume":"10","author":"J Jankovic","year":"1987","unstructured":"Jankovic J, Casabona J (1987) Coexistent tardive dyskinesia and parkinsonism. Clin Neuropharmacol 10:511\u2013521","journal-title":"Clin Neuropharmacol"},{"key":"BF02245832_CR24","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1192\/bjp.138.4.297","volume":"138","author":"DV Jeste","year":"1981","unstructured":"Jeste DV, Wyatt RJ (1981) Changing epidemiology of tardive dyskinesia: an overview. Am J Psychiatry 138:297\u2013309","journal-title":"Am J Psychiatry"},{"key":"BF02245832_CR25","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1523\/JNEUROSCI.11-12-03822.1991","volume":"11","author":"GA Jicha","year":"1991","unstructured":"Jicha GA, Salamone JD (1991) Vacuous jaw movements and feeding deficits in rats with ventrolateral striatal dopamine depletion: possible relation to parkinsonian symptoms. J Neurosci 11:3822\u20133829","journal-title":"J Neurosci"},{"key":"BF02245832_CR26","first-page":"210","volume":"37","author":"A Jus","year":"1976","unstructured":"Jus A, Pineau R, Lachance R et al. (1976) Epidemiology of tardive dyskinesia, part I. Dis Nerv Syst 37:210\u2013214","journal-title":"Dis Nerv Syst"},{"key":"BF02245832_CR27","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1001\/archpsyc.1982.04290040069010","volume":"39","author":"JM Kane","year":"1982","unstructured":"Kane JM, Smith JM (1982) Tardive dyskinesia: prevalence and risk factors, 1959\u20131979. Arch Gen Psychiatry 39:473\u2013481","journal-title":"Arch Gen Psychiatry"},{"key":"BF02245832_CR28","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/978-3-642-70140-5_9","volume-title":"Dyskinesia \u2014 research and treatment","author":"JM Kane","year":"1985","unstructured":"Kane JM, Woerner M, Leiberman J (1985) Tardive dyskinesia: prevalence, incidence, risk factors. In: Casey DE, Chase TN, Christensen AV et al. (eds) Dyskinesia \u2014 research and treatment. Springer, Berlin, pp 72\u201378"},{"key":"BF02245832_CR29","first-page":"254","volume":"22","author":"JM Kane","year":"1986","unstructured":"Kane JM, Woerner M, Borenstein M (1986) Integrating incidence and prevalence of tardive dyskinesia. Psychopharmacol Bull 22:254\u2013258","journal-title":"Psychopharmacol Bull"},{"key":"BF02245832_CR30","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1192\/bjp.118.546.509","volume":"118","author":"PF Kennedy","year":"1971","unstructured":"Kennedy PF, Hershon HI, McGuire RJ (1971) Extrapyramidal disorders after prolonged phenothiazine therapy. Br J Psychiatry 118:509\u2013518","journal-title":"Br J Psychiatry"},{"key":"BF02245832_CR31","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1176\/ajp.137.8.900","volume":"137","author":"HL Klawans","year":"1980","unstructured":"Klawans HL, Goetz CG, Perlik S (1980) Tardive dyskinesia, review and update. Am J Psychiatry 137:900\u2013908","journal-title":"Am J Psychiatry"},{"key":"BF02245832_CR32","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/0091-3057(85)90091-7","volume":"23","author":"WR Klemm","year":"1985","unstructured":"Klemm WR (1985) Neuroleptic-induced catalepsy: a D2 blockade phenomenon? Pharmacol Biochem Behav 23:911\u2013915","journal-title":"Pharmacol Biochem Behav"},{"key":"BF02245832_CR33","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0014-2999(91)90321-G","volume":"201","author":"N Koshikawa","year":"1991","unstructured":"Koshikawa N, Beltran KK, Tomiyama K, Kobayashi M, Cools AR (1991) Functional interaction between dopamine D1 and D2 receptors in rat jaw movements. Eur J Pharmacol 201:47\u201351","journal-title":"Eur J Pharmacol"},{"key":"BF02245832_CR34","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0006-8993(75)90384-4","volume":"88","author":"H K\u00fcnzle","year":"1975","unstructured":"K\u00fcnzle H (1975) Bilateral projections from precentral motor cortex to the putamen and other parts of the basal ganglia. Brain Res 88:195\u2013209","journal-title":"Brain Res"},{"key":"BF02245832_CR35","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1192\/bjp.140.6.587","volume":"140","author":"RG McCreadie","year":"1982","unstructured":"McCreadie RG, Barron ET, Winslow GS (1982) The Nithsdale schizophrenia survey: II. Abnormal movements. Br J Psychiatry 140:587\u2013590","journal-title":"Br J Psychiatry"},{"key":"BF02245832_CR36","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/ana.410250521","volume":"25","author":"MM Mouradian","year":"1989","unstructured":"Mouradian MM, Heuser IJE, Baroni F, Fabbrini G, Juncos JL, Chase TN (1989) Pathogenesis of dyskinesias in Parkinson's disease. Ann Neurol 25:523\u2013526","journal-title":"Ann Neurol"},{"key":"BF02245832_CR37","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1001\/archpsyc.1982.04290040064009","volume":"39","author":"S Mukherjee","year":"1982","unstructured":"Mukherjee S, Rosen AM, Cardenas C, Varia V, Olarte S (1982) Tardive dyskinesia in psychiatric outpatients. Arch Gen Psychiatry 39:466\u2013469","journal-title":"Arch Gen Psychiatry"},{"key":"BF02245832_CR38","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000125496","volume":"1","author":"L Munkvad","year":"1968","unstructured":"Munkvad L, Pakkenberg H, Randrup A (1968) Aminergic systems in the basal ganglia associated with stereotyped hyperactive behaviour and catalepsy. Brain Behav Evo. 1:89\u2013100","journal-title":"Brain Behav Evo."},{"key":"BF02245832_CR39","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0014-2999(89)90093-9","volume":"160","author":"AM Murray","year":"1989","unstructured":"Murray AM, Waddington JL (1989) The induction of grooming and vacuous chewing by a series of selective D-1 dopamine receptor agonists. Eur J Pharmacol 160:377\u2013384","journal-title":"Eur J Pharmacol"},{"key":"BF02245832_CR40","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF00179179","volume":"90","author":"SO \u00d6gren","year":"1986","unstructured":"\u00d6gren SO, Hall H, K\u00f6hler C, Magnusson O, Sj\u00f6strand S-E (1986) The selective dopamine D2 antagonist raclopride discriminates between dopamine-mediated behaviomotor functions. Psychopharmacology 90:287\u2013294","journal-title":"Psychopharmacology"},{"key":"BF02245832_CR41","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0014-2999(90)90291-D","volume":"182","author":"K Ossowska","year":"1990","unstructured":"Ossowska K, Karcz M, Wardas J, Wolfarth S (1990) Striatal and nucleus accumbens D1\/D2 dopamine receptors in neuroleptic catalepsy. Eur J Pharmacol 182:327\u2013334","journal-title":"Eur J Pharmacol"},{"key":"BF02245832_CR42","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0304-3940(89)90031-1","volume":"105","author":"SA Parashos","year":"1989","unstructured":"Parashos SA, Marin C, Chase TN (1989) Synergy between a selective D1 antagonist and a selective D2 antagonist in the induction of catalepsy. Neurosci Lett 105:169\u2013173","journal-title":"Neurosci Lett"},{"key":"BF02245832_CR43","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1176\/ajp.139.11.1526-a","volume":"139","author":"MA Richardson","year":"1982","unstructured":"Richardson MA, Craig TJ (1982) The coexistence of parkinsonism-like symptoms and tardive dyskinesia. Am J Psychiatry 139:341\u2013343","journal-title":"Am J Psychiatry"},{"key":"BF02245832_CR44","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0024-3205(86)90434-0","volume":"39","author":"H Rosengarten","year":"1986","unstructured":"Rosengarten H, Schweitzer JW, Friedhoff AJ (1986) Selective dopamine D2 receptor reduction enhances a D1 mediated oral dyskinesia in rats. Life Sci 39:29\u201335","journal-title":"Life Sci"},{"key":"BF02245832_CR45","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/jama.1991.03470170090030","volume":"266","author":"B Saltz","year":"1991","unstructured":"Saltz B, Woerner M, Kane J et al. (1991) Prospective study of tardive dyskinesia in the elderly. JAMA 266:2402\u20132406","journal-title":"JAMA"},{"key":"BF02245832_CR46","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/284472a0","volume":"284","author":"PR Sanberg","year":"1980","unstructured":"Sanberg PR (1980) Haloperidol-induced catalepsy is mediated by postsynaptic dopamine receptors. Nature 284:472\u2013473","journal-title":"Nature"},{"key":"BF02245832_CR47","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1001\/archpsyc.1980.01780250054006","volume":"37","author":"JM Smith","year":"1980","unstructured":"Smith JM, Baldessarini RJ (1980) Changes in prevalence, severity, recovery in tardive dyskinesias with age. Arch Gen Psychiatry 37:1368\u20131373","journal-title":"Arch Gen Psychiatry"},{"key":"BF02245832_CR48","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1176\/ajp.136.8.1098","volume":"136","author":"JM Smith","year":"1979","unstructured":"Smith JM, Dunn DD (1979) Sex differences in the prevalence of severe tardive dyskinesia. Am J Psychiatry 136:1080\u20131082","journal-title":"Am J Psychiatry"},{"key":"BF02245832_CR49","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF02257414","volume":"111","author":"RE Steinpreis","year":"1993","unstructured":"Steinpreis RE, Baskin P, Salamone JD (1993) Vacuous jaw movements induced by sub-chronic administration of haloperidol: interactions with scopolamine. Psychopharmacology 111:99\u2013105","journal-title":"Psychopharmacology"},{"key":"BF02245832_CR50","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/BF00451690","volume":"98","author":"AJ Stoessl","year":"1989","unstructured":"Stoessl AJ, Dourish CT, Iversen SD (1989) Chronic neuroleptic-induced mouth movements in the rat: suppression by CCK and selective dopamine D1 and D2 receptor antagonists. Psychopharmacology 98:372\u2013379","journal-title":"Psychopharmacology"},{"key":"BF02245832_CR51","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0165-1781(87)90110-7","volume":"22","author":"R Tomer","year":"1987","unstructured":"Tomer R, Mintz M, Kempler S, Sigal M (1987) Lateralized neuroleptic-induced side-effects are associated with asymmetric visual-evoked potentials. Psychiatry Res 22:311\u2013318","journal-title":"Psychiatry Res"},{"key":"BF02245832_CR52","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/BF02244220","volume":"101","author":"JL Waddington","year":"1990","unstructured":"Waddington JL (1990) Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: phenomenology, pathophysiology and putative relationship to tardive dyskinesia. Psychopharmacology 101:431\u2013447","journal-title":"Psychopharmacology"},{"key":"BF02245832_CR53","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0033-3182(82)73379-1","volume":"23","author":"ME Wolf","year":"1982","unstructured":"Wolf ME, Ryan JJ, Mosnaim AD (1982) Organicity and tardive dyskinesia. Psychosomatics 23:475\u2013480","journal-title":"Psychosomatics"},{"key":"BF02245832_CR54","first-page":"1181","volume":"18","author":"ME Wolf","year":"1983","unstructured":"Wolf ME, Chevesich J, Lehre, E, Mosnaim AD (1983) The clinical association of tardive dyskinesia and drug-induced parkinsonism. Biol Psychiatry 18:1181\u20131188","journal-title":"Biol Psychiatry"},{"key":"BF02245832_CR55","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/S0033-3182(84)72946-X","volume":"25","author":"R Yassa","year":"1984","unstructured":"Yassa R, Nair V, Schwartz G (1984) Tardive dyskinesia: a two-year follow-up study. Psychosomatics 25:852\u2013855","journal-title":"Psychosomatics"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02245832.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02245832\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02245832","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T17:33:29Z","timestamp":1557941609000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02245832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,3]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1995,3]]}},"alternative-id":["BF02245832"],"URL":"https:\/\/doi.org\/10.1007\/bf02245832","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,3]]}}}